Advert - Roche – Case AUTH/3646/5/22

For omitting important safety information from the dosing webpage of the Rozlytrek (entrectinib) promotional website that a health professional would expect to have been made aware of on such a webpage, Roche was ruled in breach of the following Clauses of the 2021 Code:

Clause 2           - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 5.1        - Failing to maintain high standards

Clause 6.1        - Providing misleading information